NYSE EURONEXT - EURONEXT PARIS · ABVX
-0.88% · -$1.24 · Vol 837.7K
Market closed · last close 4:00 PM ET · price as of 17:30:27 ET
Abivax SA

Abivax SA

Biotechnology
$139.50
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

Score not reportedVeridion does not publish a score-history trend for ABVX until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
NO SCORE SNAPSHOT COVERAGE
AI Analysis
Sovereign

Why is ABVX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for ABVX are being assembled.
About Abivax SA
Biotechnology
Listed since
2023
Employees
69
Country
FR

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$140.74
Day high
$141.00
Day low
$137.72
Previous close
$140.74
52W high
$141.00
-1.06% from high
52W low
$137.72
54% of range
Market cap
$12.3B
EPS
$-5.3140
Shares out
87.2M
Volume
837.7K
VWAP
$139.59
Price history computed in-house
SMA 50 Not reported · Not reported
SMA 200 Not reported · Not reported
52W position 54%
Veridion warehouse edge

Warehouse intelligence for ABVX.

Veridion Score
Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ABVX insider activity

Abivax SA

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ABVX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ABVX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ABVX in this window.
Lobbying spend

ABVX lobbying filings, year to date.

Registered lobbying filings matched to Abivax SA.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ABVX in this window.
Latest news · ABVX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ABVX.
Options
Sovereign unlock shows live options positioning for ABVX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.